Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism.

Link to article at PubMed

Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism.

Thromb Res. 2020 May 15;:

Authors: Galeano-Valle F, Oblitas CM, Ferreiro-Mazón MM, Alonso-Muñoz J, Del Toro-Cervera J, Demelo-Rodríguez P

Abstract
•COVID-19 pneumonia could be associated with an increased risk of venous thrombosis.•Antiphospholipid antibodies might be involved in thrombosis in COVID-19 patients.•Prevalence of antiphospholipid antibodies in COVID-19 and venous thrombosis was low.

PMID: 32425261 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published.